美国推出新一轮的单边关税政策 1 2025年4月2日，在美国的"解放日"中，美国政府宣布了国家紧急状态并推出了覆盖所有美国贸易伙伴 的"互惠"(reciprocal)关税政策。而在此之前，已经有多项针对其主要贸易伙伴（如中国，加拿大、墨 西哥等）的关税政策出台，部分已经进入执行状态。 在2024年，美国的进出口逆差超过了1.2万亿美元 1 ，在此情况下这一次的关税体现了两个特点，第 一为覆盖范围广——覆盖所有贸易伙伴，即使美国的贸易顺差国家也被加以10%的关税，第二为有针 对性的差异化税率，美国的主要贸易逆差国家和地区被加征更高的关税。 | 2 | | --- | 美国与中国的关税博弈自2018年始， 特朗普开始第二任期后再次升级 本文选自科尔尼 2025 年 4 月 8 日刊发的行业通讯，现全文分享。 中美作为全球最大的两大经济体，2024年中美双边贸易额约6800亿美元，其中美国对中国出口约 1600亿美元，美国从中国进口约5200亿美元，贸易逆差约3600亿美元 2 。 其中中国主要出口机电产品、纺织鞋服、金属制品等，美国主要出口机械电子、农产品、能源等，因 此这些行业中的企业受关税影响较大。 美国政府 ...

Group 1 - The actual controller, chairman, and CEO of Juran Smart Home, Wang Linpeng, has been detained, but the company's operations remain normal and unaffected [1] - Juran Smart Home reported a total revenue of 12.966 billion yuan in 2024, a decrease of 4.04% year-on-year, and a net profit of 883 million yuan, down 32.08% year-on-year, primarily due to economic fluctuations and increased competition in the home furnishing market [3][4] Group 2 - China Bank plans to raise up to 165 billion yuan through a private placement of A-shares, with the funds aimed at increasing its core tier one capital [4] - The issuance price for China Bank's shares is set at 6.05 yuan per share, which is 80% of the average trading price over the previous 20 trading days [4] - The Bank of Communications also plans to raise up to 120 billion yuan through a private placement, with the funds also designated for core tier one capital [5] Group 3 - SANY Heavy Industry reported a total revenue of 78.383 billion yuan in 2024, an increase of 5.9% year-on-year, and a net profit of 5.975 billion yuan, up 31.98% year-on-year [6][7] - The company's international main business revenue reached 48.513 billion yuan, accounting for 63.98% of total revenue, with significant growth in various regions [6][8] - SANY Heavy Industry has established 37 lighthouse factories and is recognized for its advanced smart manufacturing capabilities [8] Group 4 - East China Pharmaceutical achieved a total revenue of 41.906 billion yuan in 2024, a growth of 3.16%, and a net profit of 3.512 billion yuan, up 23.72% year-on-year [10][11] - The company has a robust pipeline of over 80 innovative drugs, focusing on diabetes and oncology [11][12] Group 5 - EVE Energy reported a total revenue of 48.615 billion yuan in 2024, a slight decrease of 0.35%, with a net profit of 4.076 billion yuan, an increase of 0.63% [13][14] - The company has seen significant growth in its energy storage business, with a shipment volume of 50.45 GWh, a year-on-year increase of 91.90% [15] Group 6 - China Unicom reported a revenue of 103.35 billion yuan in Q1 2025, a growth of 3.9%, and a net profit of 2.61 billion yuan, up 6.5% year-on-year [19] - Lens Technology achieved a revenue of 17.063 billion yuan in Q1 2025, a growth of 10.10%, with a net profit of 429 million yuan, up 38.71% year-on-year [20] Group 7 - Fuyao Glass reported a revenue of 9.910 billion yuan in Q1 2025, a growth of 12.16%, with a net profit of 2.030 billion yuan, up 46.25% year-on-year [21] - Zhuye Group reported a revenue of 4.803 billion yuan in Q1 2025, a growth of 8.50%, with a net profit of 277 million yuan, up 74.07% year-on-year [23] Group 8 - Cailong Technology reported a net profit growth of 87.55% in 2024, with total revenue of 11.664 billion yuan [32] - Ziyan Food reported a revenue of 3.363 billion yuan in 2024, with a net profit growth of 4.5% [33] Group 9 - Shunyi Environmental reported a revenue of 12.678 billion yuan in 2024, with a net profit growth of 41.58% [35] - Shougang Group turned a profit in Q1 2025, reporting a revenue of 26.533 billion yuan, down 10.18%, with a net profit of 328 million yuan [36] Group 10 - Keda Li reported a revenue of 12.030 billion yuan in 2024, with a net profit growth of 22.55% [38] - Betta Pharmaceuticals reported a revenue of 2.892 billion yuan in 2024, with a net profit growth of 15.67% [40] Group 11 - New Australia reported a revenue of 4.841 billion yuan in 2024, with a net profit growth of 5.96% [41] - Fawer reported a revenue of 16.468 billion yuan in 2024, with a net profit growth of 11.93% [42] Group 12 - Zhongwei Company reported a revenue of 9.065 billion yuan in 2024, with a net profit decrease of 9.53% [43] - Changying Precision reported a revenue of 16.934 billion yuan in 2024, with a net profit growth of 800% [44] Group 13 - Stanley reported a revenue of 10.263 billion yuan in 2024, with a net profit growth of 17.89% [45] - Puyang reported a revenue of 5.192 billion yuan in 2024, with a net profit decrease of 45.48% [46] Group 14 - Huangshi Group received a notice of administrative penalty for failing to disclose significant contracts, with potential fines for the company and responsible individuals [47] - Baosteel announced plans to acquire a 49% stake in Maanshan Steel through a combination of cash purchases and capital increases, with an estimated total investment of 9 billion yuan [48][49] Group 15 - Shengquan Group reported a revenue of 2.459 billion yuan in Q1 2025, with a net profit growth of 50.46% [50]

Core Viewpoint - The company reported a revenue of 1.098 billion yuan for 2024, reflecting a year-on-year growth of 15.60% [1] - The net profit attributable to shareholders reached 145 million yuan, with a year-on-year increase of 15.37% [1] - Basic earnings per share were 0.3861 yuan, marking a 15.25% growth compared to the previous year [1] Dividend and Share Distribution - The company plans to distribute a cash dividend of 1.2 yuan (including tax) for every 10 shares to all shareholders [1] - There will be no bonus shares distributed (0 shares) [1] - The company will not increase the share capital by transferring shares from the capital reserve, with a transfer of 0 shares for every 10 shares [1]

博威合金（601137）公告，2024年营业收入186.55亿元，同比增长5.06%。归属于上市公司股东的净利 润13.54亿元，同比增长20.47%。公司2024年度利润分配方案为向全体股东每10股派发现金股利5.01元 (含税)，总计派发现金股利4.06亿元，占归属于母公司股东的净利润比例为30.02%。本次利润分配不送 红股，不以公积金转增股本。 ...

Core Viewpoint - Xianglou New Materials achieved record-high operating revenue and net profit in 2024, with operating revenue reaching 1.485 billion yuan, a year-on-year increase of 9.74%, and net profit attributable to shareholders reaching 203 million yuan, a year-on-year increase of 12.26% [1] Group 1: Financial Performance - In 2024, the revenue breakdown includes 1.247 billion yuan from automotive precision stamping materials, 151 million yuan from industrial precision stamping materials, 13 million yuan from other precision stamping materials, and 73 million yuan from other businesses, with respective year-on-year growth rates of 10.05%, 13.76%, -14.69%, and 2.80% [1] Group 2: Competitive Advantages - The company has established multiple advantages in technology research, customer resources, and production capacity, holding 15 invention patents and 61 utility model patents as of the end of 2024, with R&D expenses amounting to 61 million yuan, a year-on-year increase of 20.21% [2] - Xianglou New Materials has formed long-term stable partnerships with renowned automotive parts suppliers, and its products are widely used by brands such as Tesla, BYD, and BMW [2] Group 3: Growth Strategy - The company is actively exploring a second growth curve by establishing a Robotics Materials Research Institute to focus on overcoming technical challenges in precision stamping materials and lightweight applications, aiming for technological breakthroughs through independent research and development [3] - The establishment of the research institute is a strategic move to open new growth opportunities and capitalize on the rapid development of humanoid robots [3]

点击注册小程序 查看完整报告 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 今 日 聚 焦 【基础化工】中方对美实施关税反制，战略看好粮食安全主线——基础化工行业动态跟踪 当 地时间 25年4月2日，美国总统特朗普在白宫签署关于所谓"对等关税"的行政令，宣布美国对贸易伙伴 加征10%的"最低基准关税"，并对某些贸易伙伴征收更高关税。 （赵乃迪/胡星月） 2025-04-09 您可点击今日推送内容的第1条查看 【医药】进口替代有望加速，关注国产手术机器人市场份额攀升——手术机器人行业跟踪报告 国内手术机器人行业起步较晚，以商业化成熟度较高的腔镜手术机器人行业为例，国内市场基本由美国直 觉外科公司的达芬奇手术机器人垄断，随着多款国产手术机器人获批上市，达芬奇的垄断被逐步打破。 （王明瑞/吴佳青）2025-04-09 ...

Financial Performance - The company reported a basic earnings per share of -0.2112 yuan for 2024, a decrease of 285.4% compared to -0.0548 yuan in 2023 [1] - The net profit for 2024 was -1.92 billion yuan, a significant decline of 284% from -0.5 billion yuan in 2023 [1] - The operating revenue increased by 22.51% to 65.79 billion yuan in 2024, up from 53.7 billion yuan in 2023 [1] - The return on equity was -3.60% in 2024, a drop of 295.6% from -0.91% in 2023 [1] Shareholder Information - The top ten unrestricted shareholders collectively hold 17,795.62 million shares, accounting for 24.84% of the circulating shares, with a decrease of 141.34 million shares compared to the previous period [1] - The largest shareholder, Du Chengcheng, holds 5,606.29 million shares, representing 7.82% of the total share capital, with no change in holdings [2] - Chen Bin, another shareholder, reduced his holdings by 150 million shares, now holding 1,360 million shares, which is 1.90% of the total [2] Dividend Distribution - The company announced a dividend distribution plan of 0.1 yuan per share (including tax) [3]

Financial Performance - The basic earnings per share for 2024 is 0.0137 yuan, a decrease of 78.04% compared to 0.0624 yuan in 2023 [1] - The operating revenue for 2024 is 340 million yuan, down 21.84% from 435 million yuan in 2023 [1] - The net profit for 2024 is 7 million yuan, a decline of 78.13% from 32 million yuan in 2023 [1] - The return on equity for 2024 is 2.67%, a significant drop of 79.65% from 13.12% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 196.50 million shares, accounting for 38.39% of the circulating shares, with a decrease of 9.87 million shares compared to the previous period [1] - The largest shareholder, Nanning Yiran Elderly Care Industry Partnership, holds 15.36 million shares, representing 30.00% of the total share capital, with no change [2] - New entrants among the top shareholders include Yang Yan, Chen Fengxi, Liu Kaijun, Zhang Xiu, and Tan Yanbo, while Jiang Rirong, Suzhou Shanren Venture Capital Partnership, Chen Zhehui, Zhang Xiaomin, and Chen Yan have exited [2] Dividend Distribution - The company has announced no distribution or capital increase for the current period [3]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [6][55]. Core Views - The company's performance in 2024 was negatively impacted by a decline in vanadium product prices, leading to a revenue drop of 8.15% year-on-year to 132.09 billion yuan and a significant net profit decrease of 73.03% to 2.85 billion yuan [10][55]. - The company is a major global supplier of vanadium products and is expected to benefit from the recovery of the vanadium industry and the expansion of the vanadium battery application market, with projected net profits of 5.92 billion yuan, 7.83 billion yuan, and 9.32 billion yuan for 2025-2027 [55]. Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 132.09 billion yuan, down 8.15% year-on-year, and a net profit of 2.85 billion yuan, down 73.03% year-on-year. The adjusted net profit was 2.53 billion yuan, a decrease of 75.87% [10][55]. - The fourth quarter of 2024 saw a revenue of 27.35 billion yuan, a year-on-year decline of 15.16% and a quarter-on-quarter decline of 17.52%. The net profit for Q4 was 1.02 billion yuan, down 45.91% year-on-year but up 122.04% quarter-on-quarter [10][55]. Sales Volume and Pricing - In 2024, vanadium product sales increased by 6.74% to 53,600 tons, while titanium dioxide sales grew by 1.10% to 258,000 tons. However, titanium slag sales fell by 24.18% to 146,100 tons [19][55]. - The company's gross margin decreased by 6.81 percentage points to 7.59%. The market price of vanadium pentoxide dropped by 26% year-on-year, while titanium dioxide and titanium slag prices increased by 2% and 17%, respectively [19][55]. Future Outlook - The company is positioned as a leading global supplier of vanadium products, with a comprehensive production capacity that includes 175,000 tons of titanium concentrate and 44,200 tons of vanadium products annually [43][55]. - The vanadium battery business is expected to be a significant growth driver, with a partnership established to supply 20,000 tons of ammonium vanadate in 2025, representing a 35% increase from 2024 sales [44][55]. - The company has successfully launched a 60,000-ton molten salt chlorination titanium dioxide project, enhancing its market influence [44][55]. Investment Projections - The company forecasts net profits of 5.92 billion yuan, 7.83 billion yuan, and 9.32 billion yuan for 2025, 2026, and 2027, respectively, with corresponding price-to-earnings ratios of 40, 30, and 26 [55][56]. - Revenue is expected to grow to 138.7 billion yuan in 2025, with a projected growth rate of 5.0% [54][55].

Investment Rating - The report initiates coverage with a "Buy" rating for the company [6][55]. Core Views - The company's performance in 2024 was negatively impacted by a decline in vanadium product prices, leading to a revenue drop of 8.15% year-on-year to CNY 13.209 billion and a significant net profit decrease of 73.03% to CNY 285 million [10][55]. - The company is a major global supplier of vanadium products and has a strong production capacity, which positions it well for future growth as the vanadium industry recovers and the vanadium battery market expands [3][55]. Summary by Sections Financial Performance - In 2024, the company achieved a revenue of CNY 132.09 billion, down 8.15% year-on-year, and a net profit attributable to shareholders of CNY 2.85 billion, down 73.03% [10]. - The fourth quarter of 2024 saw a revenue of CNY 27.35 billion, a year-on-year decrease of 15.16% and a quarter-on-quarter decrease of 17.52% [10]. - The sales volume of vanadium products increased by 6.74% to 53,600 tons, while titanium dioxide sales grew by 1.10% to 258,000 tons, and titanium slag sales fell by 24.18% to 146,100 tons [19]. Price and Margin Analysis - The company's gross margin decreased by 6.81 percentage points to 7.59% in 2024, with vanadium product prices dropping by 26% year-on-year [2][19]. - The gross margin for vanadium products fell by 17.05 percentage points to 10.40%, while titanium products saw a slight margin decline [2]. Future Outlook - The company is positioned as a leading global supplier of vanadium products, with a comprehensive production capacity that includes 442,000 tons of vanadium products and 300,000 tons of titanium dioxide annually [3]. - The vanadium battery business is expected to be a significant growth driver, with a partnership established to supply 20,000 tons of ammonium vanadate in 2025, representing a 35% increase from 2024 [44]. - A new 60,000-ton molten salt chlorination titanium dioxide project was launched in 2024, enhancing the company's market influence [4]. Earnings Forecast - The company is projected to achieve net profits of CNY 5.92 billion, CNY 7.83 billion, and CNY 9.32 billion from 2025 to 2027, with corresponding price-to-earnings ratios of 40, 30, and 26 [55]. - Revenue is expected to grow to CNY 138.7 billion in 2025, with a year-on-year growth rate of 5% [54].